| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: QUIN |
| Security Type |
Common Stock |
| Lead Underwriter |
Adams Harkness & Hill Inc |
| Days In Registration |
73 |
| Date Filed |
22-Feb-2002 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture and market diagnostic cardiology equipment used in the diagnosis, treatment, and rehabilitation of patients with cardiovascular disease |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
11.32M |
| Contact |
- |
| Number of Employees |
361 |
|
| Original Filing Information |
| US |
| Shares Filed |
3.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
3.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
600.0K |
| File Amount |
$49.0M |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
Current Filing Information
(Amended 6-May-2002) |
|
US |
|
Shares Filed |
4.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
4.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$28.0M |
| · % Change from Original |
-42.86 |
| File Price Range |
$7.00 - $7.00 |
| File Mid Price |
$7.00 |
|
